InvestorsHub Logo
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: TomP1 post# 35328

Friday, 05/20/2016 1:52:13 PM

Friday, May 20, 2016 1:52:13 PM

Post# of 48316
Agreed. However he is pointing out the valuation gap of $800M between the two companies when apparently ONCS has had better clinical data. This helps the stock.